BioPharm International-01-01-2021

BioPharm International January 2021 Issue

Can Cell and Gene Therapies Achieve Their Full Potential?

January 02, 2021

Development

34

01

Advances in development, data management, and automation, and closer collaboration with contract development and manufacturing partners, are pushing more therapies closer to commercialization.

Pandemic Control to Shape Biopharma in 2021

January 01, 2021

Regulatory Beat

34

01

The incoming administration faces key decisions on drug testing and access as well as vaccine distribution challenges.

Ensuring Vaccine Supply Meets Need

January 01, 2021

From the Editor

34

01

Shutting down the COVID-19 pandemic requires a global, selfless effort.

Now is the Time to Update the Quality Technical Agreement

January 01, 2021

Ask The Expert

34

01

Updating the quality technical agreement will clarify any expectations and limitations, says Siegfried Schmitt, vice president, Technical at Parexel.